PolistenaB.; SpandonaroF.; CapraR.; FantacciniS.; SantoniL.; ZimatoreG.; GasperiniC. The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study. Global & Regional Health Technology Assessment, v. 6, n. 1, 12 jun. 2019.